SLC16A1 and neoplasm: Interestingly, the non-steroidal anti-inflammatory drug (NSAID) diclofenac was found to be a potent inhibitor of MCT1/4 and to reduce intra-tumoral lactate levels, concomitant with inhibition of tumor growth and Treg infiltration in a glioma model (152).